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Summary Ninety-two consecutive adult patients admitted with acute life-threatening complications of
haematological malignancy were studied to determine long term outcome. The quality of life was evaluated in
seven long term survivors who are currently alive more than I year after hospital discharge using three
validated methods: the Nottingham Health Profile, the Hospital Anxiety and Depression Scale and the
Perceived Quality of Life Scale. Patients were also asked whether they had returned to work, whether their
daily activities were limited and whether they would be willing to undergo intensive care again under the same
circumstances. The in-hospital mortality rate was 77%. Median duration of long term survival was 23 months
(range 6 weeks to 8 years). Long term survival did not appear to be related to either the aetiology or the
severity of the acute illness, but seemed to be determined solely by the nature and progress of the underlying
malignancy. The quality of life of six of the seven long term survivors is good, while that of the other is
acceptable. None of the patients reported any increased limitation of their daily activities, five had returned to
full time employment and all seven stated that they would be willing to undergo intensive care again under the
same circumstances.
Although hospital mortality rates are very high when patients
with haematological malignancy develop an acute life-threat-
ening illness, it is now clear that for a small but significant
proportion of these patients intensive care is life-saving
(Anger et al., 1987; Brunet et al., 1990; Estopa et al., 1984;
Hauser et al., 1982; Johnson et al., 1986; Lloyd-Thomas et
al., 1988; Peters et al., 1988; Schuster & Marion, 1983; Snow
et al., 1979). When assessing the value of intensive care it is,
however, essential to consider not only immediate mortality
rates but also both the long term prognosis and quality of
life of those who do survive to leave hospital. A number of
studies have assessed in unit and hospital mortality rates for
patients with acute medical complications of haematological
malignancy, and some have identified factors associated with
a poor short term outcome (Johnson et al., 1986; Lloyd-
Thomas et al., 1988; Schuster & Marion, 1983), but there is
only limited information on the long term prognosis of those
who do survive to leave hospital (Brunet et al., 1990; Peters
et al., 1988) and the quality of life of long term survivors has
not previously been assessed.
The objective of this study was to evaluate long term
outcome and quality of life in patients discharged from hos-
pital following intensive care for life-threatening medical
complications of haematological malignancy. We also sought
to identify factors which might influence long term prognosis
in such cases.
Methods
The records of all adults admitted to the intensive care unit
at this hospital with life-threatening medical complications of
haematological malignancy during the 10 year period Jan-
uary 1980 to December 1989 were reviewed retrospectively.
The severity of the acute illness was assessed by the
APACHE II score calculated from the most abnormal var-
iables recorded during the first 24 h of admission (Knaus et
al., 1985).
The nature of the acute illness, the underlying malignancy
and the number of failed organs were also noted for each
patient.
Patients were categorised as non-survivors (death in the
intensive care unit or after discharge to the general ward) and
survivors (discharge from hospital). The mortality in hospital
and survival times for those who were discharged from hos-
pital were determined.
The quality of life of those patients currently alive more
than 1 year after discharge from hospital (seven patients) was
evaluated using three validated measures: the Nottingham
Health Profile, the Hospital Anxiety and Depression Scale
and the Perceived Quality of Life Scale, each of which
assesses different aspects of quality of life (Hunt et al., 1986;
Patrick et al., 1988; Zigmond & Snaith, 1983). The question-
naires were mailed to the seven patients after they had been
contacted by telephone.
The Nottingham Health Profile (NHP)
The NHP (Hunt et al., 1986) is a two-part self administered
questionnaire designed to measure perceived health problems
and the extent to which such problems affect normal activ-
ities. Part I contains 38 statements covering feelings and
functions in six areas: pain, energy, physical mobility, sleep,
social isolation and emotional reactions. The answers to
these statements are scored on a scale of 0-100 for each
category. Lower scores indicate fewer difficulties. Part II
contains seven yes/no questions examining the impact of
health problems on occupation, ability to perform domestic
tasks, personal relationships, sex life, social life, hobbies and
holidays.
The Hospital Anxiety andDepression Scale (HAD)
The HAD (Zigmond & Snaith, 1983) is a brief but reliable
technique for detecting states of anxiety and depression, it
consists of two sets of seven questions with four point re-
sponse scales. Each answer is scored on a scale of 0 to 3, the
sum of the individual scores give an overall depression and
anxiety score. Scores of greater than ten indicate significant
anxiety or depression; scores of less than eight are not
significant; and scores of 8-10 are of borderline significance.
The Perceived Quality ofLife Scale (PQOL)
The PQOL (Patrick et al., 1988) assesses the patients own
perception of their quality of life based on their satisfaction,
on a scale of 0 to 100, with 11 items, describing fundamental
needs of daily living (Table I). Higher scores indicate greater
satisfaction.
The patients were also asked a number of other pertinent
questions: whether they had returned to work, whether there
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was any increased limitation in their daily activities and
would they be willing to undergo intensive care again under
the same circumstances.
Statistical methods
The relationship between the APACHE II score of the long
term survivors and the duration of survival was assessed by
regression analysis.
Table I Perceived quality of life scale
'How Satisfied are you on a Scalefrom 0-100 with ....?'
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
The health of your body (HEALTH)
Your ability to think and remember (THINKING)
How happy are you (HAPPINESS)
How much you see your family and friends (FAMILY)
The help you get from family and friends (HELP)
Your contribution to the community (COMMUNITY)
Your activities outside work (LEISURE)
How your income meets your needs (INCOME)
How respected you are by others (RESPECT)
The meaning and purpose of your life (MEANING)
With working/not working/retirement (WORK)
Results
Patientpopulation andsurvival
Ninety-two patients (58 male, 34 female) were admitted dur-
ing the 10 years (Table II). Seventy-one patients (77%) died
in hospital, of whom 60 died in the intensive care unit and 11
died shortly after discharge to the general ward.
Twenty-one patients (23%) were discharged from hospital
alive. Their median duration of survival was 23 months
(range 6 weeks to 8 years). Eighteen patients (86%) were still
alive after 6 months, 13 patients (62%) after 1 year, and nine
patients (43%) after 3 years. Eight of the 21 survivors are
currently still alive at 8, 7, 7, 5, 4, 3, 3 years and 4 months
after leaving hospital (Table III). Of these hospital survivors,
18 (68%) were admitted with acute respiratory failure, comp-
licated in two by septic shock. Their median APACHE II
score was 21 (range 12-26), and the median number offailed
organs was two (range 1-3).
There was no relationship between the severity of the acute
illness as assessed by the APACHE II score and the duration
of long term survival (r = 0.1). The number of failed organs
was not a good predictor of long term prognosis as three of
the four longest survivors had failure of three organs during
their acute illness. Neither did the aetiology of the acute
illness appear to influence long term -survival. Although two
of the five patients alive 4 years or more after discharge were
admitted with relatively simple acute problems (post-opera-
Table II Patient population and survival
No. of APACHE II score ICU Ward
Disease patients Median Range deaths deaths Survivors
Acute myeloid 33 28 14-48 21 4 8
leukaemia
Acute lymphatic 23 25 14-36 13 2 8
leukaemia
Chronic myeloid 4 23 18-30 2 1 1
leukaemia
Chronic lymphatic 1 28 0 1 0
leukaemia
Multiple myeloma 3 24 21-37 3 0 0
Hodgkin's lymphoma 7 24 18-35 5 1 1
Non-Hodgkin's
lymphoma 21 25 12-44 16 2 3
Totals 92 60 11 21
Table III Details of the 21 hospital survivors
APACHE II Duration of
Patient Diagnosis Age Sex Acute illness score Organfailure survival
1. ALL 46 M P,RF,ARF 23 2 6 weeks
2. ALL 16 M P,RF 18 1 4 monthsa
3. ALL 22 M URTO 24 1 5 months
4. ALL 45 M P,RF 18 1 6 months
5. ALL 46 M P,RF 20 1 7 months
6. ALL 38 F P,RF 16 2 1 yr2 mths
7. ALL 20 F P,RF 24 2 3yrs 8 mths
8.b ALL 21 F P, RF, S, C 22 3 7 years'
9. AML 24 F P,RF 21 1 3months
10. AML 59 F URTO 14 1 7 months
11. AML 21 M P,RF, S 19 3 8months
12. AML 38 M P,RF 21 2 1 yr 11 mths
13. AML 53 M P,RF, SS 25 3 2yrs 3 mths
14. AML 46 M P, RF 17 1 3 yrs 2 mthsa
5.b AML 21 F P, RF 22 1 3 yrs 6 mthsa
16.b AML 30 M P, RF, SS 25 3 8 yearsa
17." CML 65 M H 24 1 5yearsa
18. NHL 58 F Post-op RF 17 1 6 months
19. NHL 36 F P,RF 12 3 3 yrs 10 mths
20. NHL 35 F Post-op RF 12 3 7 years'
21. HL 19 F S, RF 26 3 4 years'
aPatients who are still alive; bpatients undergoing quality of life evaluation. Abbreviations:
P = pneumonia, RF = respiratory failure, ARF = acute renal failure, H = haemorrhage, URTO = upper
respiratory tract obstruction, S = septicaemia, SS= septic shock, C = convulsion.
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tive respiratory failure and uncontrolled haemorrhage), the
other three were suffering from pneumonia and respiratory
failure complicated by septicaemia or septic shock.
All of the 13 patients who died subsequent to hospital
discharge did so as a result of uncontrolled malignancy. No
patient with relapsed malignancy survived to leave hospital
and all but one of the long term survivors had received only
their first induction therapy at the time of intensive care
admission. Patient 13 had received his second induction
therapy.
Quality oflife
Nottingham Health Profile Three patients were free ofprob-
lems in all six areas examined in Part I and the same three
patients were free of all seven problems in Part II.
Three patients reported problems in two areas assessed in
both Parts I and II of the NHP questionnaire.
The remaining patient reported problems in four areas
evaluated in both parts; these were predominantly social and
domestic.
Figure 1 illustrates the mean scores for each of the six
areas evaluated in the NHP Part I in haematological malig-
nancy patients following intensive care compared with levels
expected for community-based age/sex norms, patients with
minor non-acute conditions (e.g. varicose veins, hernias,
haemorrhoids) and fracture victims 8 weeks following the
fracture (Hunt et al., 1986).
Results indicate that patients with haematological malig-
nancy who survive intensive care have fewer problems in all
areas except social isolation than patients with minor non-
acute conditions and fracture victims, and their mean scores
were broadly similar to those of the age/sex norms in a
general population.
Hospital Anxiety and Depression Scale Only one patient
scored greater than ten and was considered to be anxious.
Two patients had scores suggesting they were borderline. No
patient was considered to be depressed, although one patient
had a borderline score.
retirement and the other patient was not working even before
her illness.
None of the seven patients reported any increased limita-
tions in their daily activities following hospital discharge and
two patients improved.
Significantly, all seven patients stated that under the same
circumstances they would be willing to undergo similar inten-
sive care treatment again.
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Figure 1 Nottingham Health Profile Part I. Comparison of
mean scores in patients with haematological malignancy ( _ ),
minor non-acute conditions ( ), fracture victims ( M ), and
age/sex controlled community population ( 3 ).
Perceived Quality ofLife Scale Figure 2 illustrates the com-
parison of mean PQOL scores between our surviving haema-
tological malignancy patients and a group of patients more
than 50 years old who had been discharged home following
admission to the medical intensive care unit in North Carol-
ina Memorial Hospital in 1983 (Patrick et al., 1988). Most of
the patients with haematological malignancy expressed a
moderate to high level of satisfaction with their quality of
life. The greatest satisfaction was expressed for the help that
they received from family and friends. The lowest satisfaction
concerned their participation in community activities. The
haematological malignancy patients had higher mean scores
in seven ofthe 11 items tested and their mean (± s.d.) overall
score of 80.6 ± 16.6 compares favourably with the 75 ± 18
reported by Patrick et al. (1988) in medical intensive care
patients.
Additional questions Three additional questions were put to
the patients (Table IV).
Five out of the seven patients had returned to full-time
work following hospital discharge. None of these five re-
ported problems with their job in the NHP Part II question-
naire and all were reasonably satisfied with their work
(PQOL mean score ± s.d.: 86 ± 13.9). One patient took early
Thinking
Happy
Family
Help
Community
Leisure
Income
Respect
Meaning
Work
Total score
20 40 60 80 100
PQOL score
Figure 2 Perceived Quality of Life Scale. Scores for each item,
as well as the total score, are shown on the horizontal axis. =
- haematological malignancy patients; - a group ofpatients
who were discharged from the medical intensive care unit at
North Carolina Memorial Hospital.
Table IV Additional questions
Patient 1 2 3 4 5 6 7
Returned to work Yes No Yes Early Yes Yes Yes
Limitations on daily activities: retirement
3 months before Some Some None Some Severe None None
now None Some None Some Some None None
Undergo intensive care again Yes Yes Yes Yes Yes Yes Yes
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Discussion
Intensive care clinicians are frequently faced with ethical
dilemmas concerning the appropriate extent of medical inter-
vention for critically ill patients whose prognosis is poor
(Thibault et al., 1980; Wanzer et al., 1984). Not only can
intensive care be mentally and physically distressing for
patients, relatives and staff but it is also expensive, especially
for non-survivors (Cullen et al., 1976; Detsky et al., 1981;
Turnbull et al., 1979). Both for a humane approach to the
management of critically ill patients and to ensure that
limited resources are used appropriately, it is therefore im-
portant to avoid admitting patients who cannot benefit from
intensive care and to limit further aggressive therapy when
the prognosis is clearly hopeless.
Hospital mortality rates have been reported to be parti-
cularly high (69-80%) when patients with haematological
malignancy develop an acute illness of sufficient severity to
warrant intensive care admission, especially when they pre-
sent with respiratory failure (80-96%) (Anger et al., 1987;
Estopa et al., 1984; Hauser et al., 1982; Johnson et al., 1986;
Lloyd-Thomas et al., 1988; Schuster & Marion, 1983; Snow
et al., 1979). In this series of 92 adults admitted to our
intensive care unit with life threatening medical complications
of haematological malignancy, the in-hospital mortality rate
was 77%; broadly similar to that reported by others.
When evaluating the results of intensive care it is impor-
tant to consider not only immediate mortality rates but also
the duration of survival and quality of life of those who leave
hospital. Peters et al. (1988) found that of 116 patients with
haematological malignancy who required intensive care and
mechanical ventilation only 18% survived to be discharged
from hospital; their median duration of survival was 12
months with a range of 1 month to 7 years. In our 21
survivors the median duration of survival was longer at 23
months (range 6 weeks to 8 years), with eight patients cur-
rently alive. The long term survival rate was 86% at 6
months and 62% at 1 year; higher than that reported by
Brunet et al. (1990) (64% after 6 months and 44% after 1
year). The duration of long term survival did not appear to
be related to either the aetiology of the acute illness
precipitating intensive care admission, or to the severity of
the acute condition as assessed by the APACHE II score and
number of failed organs. Indeed three of our four longest
survivors received mechanical ventilation, had APACHE II
scores of 24-26 and failure of three organs. Uncontrolled
malignancy was responsible for all the deaths in those
patients who were discharged from hospital, even though
patients were not admitted to intensive care if such progres-
sion was thought to be likely at the onset of their acute
illness. Similarly, Crawford et al. (1988) found that, although
the prognosis was grave, some of his patients who developed
complications after marrow transplantation with failure of
three to four organs and who required mechanical ventilation
became long term survivors. Review of the clinical records of
these patients revealed no distinguishing characteristics in
terms of the duration or mode of ventilation, types of comp-
lication, or rapidity of recovery. The duration of long term
survival therefore appears to be determined solely by the
nature and progress of the underlying malignancy, and not
by the severity of the acute illness.
In this series, six of the seven patients currently alive more
than 1 year after discharge from hospital have a good quality
of life, broadly similar to that of the same age and sex norms
in the general population, while that of the other is accep-
table. None of the patients reported any increased physical
limitations to their daily activities following intensive care.
The majority returned to full-time employment with no prob-
lems at work. Generally, they reported a moderate to high
level of satisfaction with most aspects of their daily lives as
shown by the PQOL assessment. They all expressed great
satisfaction regarding their family life and the help and sup-
port that they received from their family and friends. Only
one patient could be considered to be suffering from anxiety
and none was depressed. Most encouragingly, all seven pa-
tients stated that under similar circumstances they would be
willing to undergo the same intensive care treatment again. It
must be recognised, however, that the quality of life of at
least some of those who died from uncontrolled malignancy
following hospital discharge, whom we have not assessed,
may have been poor.
The hospital mortality of critically ill patients with haema-
tological malignancy is undoubtedly high and the long term
prognosis for many is poor. Nevertheless, this study has
demonstrated that for a significant number intensive care is
life-saving, long term survival is possible, a number must be
presumed cured and their quality of life is good. Previous
studies have identified various factors associated with a poor
short term outcome (Johnson et al., 1986; Lloyd-Thomas et
al., 1988; Schuster & Marion, 1983) and these can be used as
guidelines when assessing the immediate prognosis ofindivid-
ual patients. Neither ourselves nor others (Crawford et al.,
1988), however, have been able to distinguish any features of
the acute illness which influence the likelihood of long term
survival; this seems to depend solely on the progress of the
underlying malignancy, something which is often difficult to
predict before or during intensive care. Despite the high
mortality rate, intensive care is therefore justified for patients
with acute life-threatening complications of haematological
malignancy, unless or until it is clear that there is no prospect
of recovery from the acute illness, or that the underlying
malignancy cannot be controlled.
Dr E. Yau was in receipt of an Aylwen Bursary through the Special
Trustees of St Bartholomew's Hospital.
We would like to thank Ms K. Rowan, UK Apache II study
co-ordinator, for helpful advice.
References
ANGER, B., SCHMEISER, T., SIGEL, H. & HEIMPEL, H. (1987). Inten-
sive care therapy for patients with haematological disease. 30,
519.
BRUNET, F., LANORE, J.J., DHAINAUT, J.F. & DREYFUS, F. (1990).
Is intensive care justified for patients with haematological malig-
nancies? Intensive Care Med., 16, 291.
CRAWFORD, S.W., SCHWARTZ, D.A., PETERSEN, F. & CLARK, J.C.
(1988). Risk factors ofmechanical ventilation after marrow trans-
plantation. Am. Rev. Respir. Dis., 137, 682.
CULLEN, D.J., FERRARA, L.C., BRIGGS, B.A., WALKER, P.F. &
GILBERT, J. (1976). Survival hospitalization charges and follow-
up results in critically ill patients. N. Engi. J Med., 294, 982.
DETSKY, A.S., STRICKER, S.C., MULLEY, A.G. & THIBAULT, G.E.
(1981). Prognosis, survival, and the expenditure of hospital
resources for patients in an intensive care unit. N. Engl. J. Med.,
305, 667.
ESTOPA, R., TORRES-MARTI, A., KASTANOS, N., RIVES, A., AGUSTI-
VIDAL, A. & ROZMAN, C. (1984). Acute respiratory failure in
severe haematologic disorders. Crit. Care Med., 12, 26.
HAUSER, M.J., TABAK, J. & BAIER, H. (1982). Survival of patients
with cancer in a medical critical care unit. Arch. Intern. Med.,
142, 527.
HUNT, S.M., MCEWEN, J. & MCKENNA, S.P. (1986). Measuring
Health Status. Croom Helm: London. Pp. 163-202.
JOHNSON, M.H., GORDON, P.W. & FITZGERALD, F.T. (1986).
Stratification of prognosis in granulocytopenic patients with
haematological malignancies using the APACHE II severity of
illness score. Crit. Care Med., 14, 693.
KNAUS, W.A., DRAPER, E.A., WAGNER, D.P. & ZIMMERMAN, J.E.
(1985). APACHE II: a severity of disease classification system.
Crit. Care Med., 13, 818.
LLOYD-THOMAS, A.R., WRIGHT, I., LISTER, T.A. & HINDS, C.J.
(1988). Prognosis of patients receiving intensive care for life-
threatening medical complications of haematological malignancy.
Br. Med. J., 296, 1025.
PATRICK, D.L., DANIS, N., SOUTHERLAND, L.I. & HONG, G. (1988).
Quality of life following intensive care. J. Gen. Intern. Med., 3,
218.942 E. YAU et al.
PETERS, S.G., MEADOWS, J.A. & GRACEY, D.R. (1988). Outcome of
respiratory failure in haematologic malignancy. Chest, 94, 99.
SCHUSTER, D.P. & MARION, J.M. (1983). Precedents for a meaning-
ful recovery during treatment in a medical intensive care unit.
Am. J. Med., 75, 402.
SNOW, R.M., MILLER, W.C., RICE, D.L. & ALI, M.K. (1979). Res-
piratory failure in cancer patients. JAMA, 241, 2039.
TURNBULL, C., CARLON, G., BARON, R., SICHEL, W., YOUNG, C. &
HOWLAND, W. (1979). The inverse relationship between cost and
survival in the critically ill cancer patient. Crit. Care Med., 7, 20.
THIBAULT, G.E., MULLEY, A.G., BARNETT, G.O., GOLDSTEIN, R.L.,
REDER, V.A. & SHERMAN, E.L. (1980). Medical intensive care:
indications, interventions, and outcomes. N. Engi. J. Med., 302,
938.
WANZER, S.H., ADELSTEIN, S.J., CRANFORD, R.E., FEDERMAN,
D.D., HOOK, E.D. & MORTEL, C.G. (1984). The physician's re-
sponsibility toward hopelessly ill patients. N. Engl. J. Med., 310,
955.
ZIGMOND, A.S. & SNAITH, R.P. (1983). The Hospital Anxiety and
Depression Scale. Psychiatr. Scand., 67, 361.